Intracranial atherosclerotic disease is a major cause of ischemic stroke. Stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis was terminated prematurely due to a high stroke and death rate in patients randomized for intracranial stent placement. However, for some patients, angioplasty and/or stent placement remains the best approach. Flow diverters (FDs) are designed to produce a hemodynamic flow diversion by constituting a laminar flow pattern in the parent artery and are mainly used in non-ruptured complex wide-neck aneurysms as well as in ruptured aneurysms. Herein, we present a case where an FD was used in a complicated angioplasty for basilar artery atherosclerosis. A 72-year-old female patient was admitted to our hospital with left side weakness and vertigo. Her diffusion magnetic resonance imaging and magnetic resonance angiography showed right-sided pontine and left-sided occipital acute infarcts with left-sided pontine and right-sided occipital chronic infarcted areas and preocclusive mid-basilar stenosis. The patient was under supervised medical treatment. Despite chronic brain stem and occipital infarcts her modified Rankin Scale was 2. Diagnostic angiography showed no posterior communicating arteries and no pial-pial collaterals and a critical mid-basilar artery stenosis. We decided to perform intracranial angioplasty to increase the perfusion of posterior circulation and reduce the risk of additional embolic infarcts. Angioplasty was complicated with dissection and vessel perforation. We used an FD for rescue therapy to avoid rebleeding. The patient was discharged with good clinical and angiographic results. F low diverters (FDs) are a new option in endovascular therapy that are particularly suitable for wide-necked aneurysms, fusiform aneurysms, very small aneurysms (<2 mm) or blister-like aneurysms, which are hard to treat. FDs can alter aneurysmal inflow such that progressive thrombosis and exclusion of the aneurysm from the circulation can be induced. Although long-term follow-up data are currently unavailable, there is accumulating evidence of good results with these devices. FDs are mostly used for non-ruptured aneurysms but there are several case reports and series where FDs are also used in ruptured aneurysms (1, 2). In this report, we present a case in which FD was used as a rescue therapy for basilar artery perforation after balloon angioplasty.
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low diverters (FDs) are a new option in endovascular therapy that are particularly suitable for wide-necked aneurysms, fusiform aneurysms, very small aneurysms (<2 mm) or blister-like aneurysms, which are hard to treat. FDs can alter aneurysmal inflow such that progressive thrombosis and exclusion of the aneurysm from the circulation can be induced. Although long-term follow-up data are currently unavailable, there is accumulating evidence of good results with these devices. FDs are mostly used for non-ruptured aneurysms but there are several case reports and series where FDs are also used in ruptured aneurysms (1, 2) . In this report, we present a case in which FD was used as a rescue therapy for basilar artery perforation after balloon angioplasty.
Case report
A 72-year-old female patient was admitted to our hospital with left side weakness and vertigo. Her diffusion weighted imaging and magnetic resonance (MR) angiography showed right-sided pontine and left-sided occipital acute infarcts with left-sided pontine and right-sided occipital chronic infarcted areas and preocclusive mid-basilar stenosis (Fig. 1) . The patient was taking oral antidiabetic and antihypertensive medicine for 20 years, as well as double antiaggregants (aspirin 100 mg, clopidogrel 75 mg) and antilipidemics for one year since her previous pontine infarct. Despite chronic brain stem and occipital infarcts, her modified Rankin Scale was 2. Diagnostic angiography showed no posterior communicating arteries and no pial-pial collaterals and a preocclusive mid-basilar artery stenosis. We performed intracranial angioplasty to increase the perfusion of posterior circulation and reduce the risk of additional embolic infarcts.
The procedure started under general anesthesia and the right femoral artery was accessed using a 6-French sheath. After insertion of the femoral sheath, an intravenous (IV) bolus of 5000 IU heparin was given. The left vertebral artery was catheterized with a 5-French vertebral catheter and a 0.035-inch, 260-cm long guidewire (Terumo, Somerset, New Jersey, USA). Additionally, a 6-French delivery catheter (Neuron, Penumbra Inc., San Diego, California, USA) was positioned in the proximal V2 segment over the exchange guidewire. After insertion of a microcatheter (Rebar 18) and a floppy-tipped exchange 0.014-inch microwire, the delivery catheter was positioned distal to the V2 segment over the microcatheter-microwire combination. The poststenotic segment of the basilar artery diameter was measured 3.3 mm and the prestenotic segment was 3.7 mm. The stenotic segment was passed with gentle microwire manipulations and then an angioplasty balloon (Gateway 3×15 mm, Boston Scientific, Natick, Massachusetts, USA) was advanced across the lesion with the exchange maneuver. The balloon diameter was sized to 80% of the "normal" parent vessel diameter. The balloon was inflated slowly under fluoroscopic roadmap guidance over several seconds to the nominal inflation pressure and kept inflated for approximately 30 s and then deflated. After balloon deflation, a control angiogram was performed and extravasation was detected (Fig. 2) . Heparin was reversed with protamine sulfate and the balloon was inflated again on the side of perforation. After three minutes of inflation, extravasation remained in the control angiogram. By this time, mild bradycardia occurred and quickly returned to normal values without any intervention. The balloon was inflated again and after four minutes of inflation time, control angiography was performed. This time there was no extravasation but a small dissection in the proximal part of the plaque. We then decided to implant an FD stent to that segment instead of an opencell stent to prevent rebleeding and cover the dissected segment. Vasco 21 microcatheter was advanced distal to the lesion over the microwire and than the Silk stent (3.5×15 mm, Balt Extrusion, Montmorency, France) was released beginning from distal basilar artery to the left V4. The opening of the stent and adequate wall apposition were evaluated by native images and control angiograms. Additional heparin or IV antiaggregants were not given because the patient was already taking aspirin and clopidogrel. The patient awakened without any difficulty and was neurologically intact. In control head computed tomography (CT), hemorrhage and contrast media was observed, especially in the interpeduncular cistern and posterior-inferior sulci of the cerebellum (Fig. 3a, 3b) . The patient was kept in the neurointensive care unit for 24 hours and discharged on the tenth day of treatment after confirming clearance of subarachnoid hemorrhage and without signs of vasospasm. During that period, the patient rarely developed mild headaches, which were responsive to analgesics.
We performed a CT angiography after the first month of treatment. The stent and both vertebral arteries were patent with no additional infarcted area compared with preprocedural imaging (Fig. 3c, 3d ).
Discussion
Intracranial atherosclerotic disease is a major cause of ischemic stroke. The annual risk of a recurrent stroke, estimated at 10% to 23% of patients with symptomatic stenosis, is high despite medical therapy (3). Stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis was evaluated in a randomized trial, which was terminated prematurely due to a high stroke and death rate in patients randomized for intracranial stent placement (4). However, for some patients, angioplasty and/or stent placement remains the best approach. Both primary angioplasty alone and angioplasty with self-expanding or balloon expanding stents have been evaluated in non-randomized trials with high technical success. A recent large meta-analysis demonstrated technical success in 80% of angioplasty-treated patients versus 95% in the stent-treated group (5). Conversely, acute or subacute arterial occlusion, vessel dissection, vessel perforation, restenosis, and transient or permanent ipsilateral stroke are major complications of these treatments with a highly variable estimated risk, reported between 0% and 36% (6) (7) (8) .
Vessel perforation or rupture is a hazardous complication of endovascular intracranial atherosclerosis treatment and is highly morbid and mortal (6) . The complication is mostly due to microwire manipulations while passing the stenotic segment, and can also occur after balloon angioplasty, especially in highly calcific plaques or after overinflation of the balloon. In the literature, the incidence of vessel rupture is reported to be 0% to 18% (6) (7) (8) . There is no specific treatment for that particular complication, but balloon reinflation in the perforated segment, reversal of heparin with protamine sulfate, and, if possible, parent artery occlusion with detachable balloons or coils are some treatment options.
FDs are designed to produce a hemodynamic flow diversion by constituting a laminar flow pattern in the parent artery with metal surface area coverage of 35%-55% in a Silk stent and 30%-35% in a Pipeline embolization device (ev3, Irvine, California, USA). Although they are mainly used in non-ruptured complex wide-neck aneurysms, there are several reports of their use in ruptured aneurysms. Tahtinen et al. (1) reported the use of a Silk stent in four ruptured aneurysms, two in the acute phase and two in subacute phase. Kulcsár et al. (2) reported three ruptured aneurysms in the subacute phase. Narata et al. (9) reported two Pipeline cases treated within the first day of hemorrhagic vertebral artery dissection. Martin et al. (10) reported three ruptured aneurysm cases, two of which were in the acute phase. In the above-mentioned cases, there was no rebleeding despite dual antiaggregant treatment, which is very promising. For our patient, the use of a self-expandable stent after balloon angioplasty was initially intended, but was reconsidered after rupture and dissection. First, we considered not placing a stent and not treating after hemostasis, but the dissection was obvious and could lead to thrombosis or emboli. Second, we decided to use an intracranial atherosclerosis stent (Wingspan Stent, Boston Scientific), but because of the delay to obtain hemostasis, the stent's open-cell design was considered not helpful in preventing rebleeding while using dual antiaggregants. We know that FDs are not a prescribed treatment for these types of ruptures; however, their previously usage in acute phase of ruptured aneurysms and up to five years follow-up data for perforator vessels patency, we consider that FDs could be helpful in this particular complication.
In conclusion, we used a FD stent for rescue therapy to cover a ruptured and dissected segment after angioplasty for intracranial atherosclerosis with excellent angiographic and clinical outcome.
